Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIC Allo-SCT for Pediatric CML
NCT02707393Phase 3Completed
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Apr 2009
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of fludarabine, melphalan, thiotepa, antithymocyte globulin rabbit in chronic myeloid leukemia (CML), sponsored by St. Anna Children's Cancer Research Institute. Started Apr 2009; status: completed.
02
Drugs
fludarabinemelphalanthiotepaantithymocyte globulin rabbit
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02707393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707393.